首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   598篇
  免费   25篇
  国内免费   6篇
耳鼻咽喉   2篇
儿科学   43篇
妇产科学   13篇
基础医学   52篇
口腔科学   34篇
临床医学   46篇
内科学   135篇
皮肤病学   14篇
神经病学   14篇
特种医学   162篇
外科学   34篇
综合类   13篇
预防医学   18篇
眼科学   3篇
药学   28篇
中国医学   1篇
肿瘤学   17篇
  2024年   1篇
  2023年   3篇
  2022年   2篇
  2021年   8篇
  2020年   7篇
  2019年   11篇
  2018年   6篇
  2017年   4篇
  2016年   4篇
  2015年   11篇
  2014年   20篇
  2013年   15篇
  2012年   6篇
  2011年   11篇
  2010年   27篇
  2009年   31篇
  2008年   22篇
  2007年   11篇
  2006年   13篇
  2005年   12篇
  2004年   10篇
  2003年   8篇
  2002年   3篇
  2001年   10篇
  2000年   13篇
  1999年   14篇
  1998年   26篇
  1997年   37篇
  1996年   45篇
  1995年   29篇
  1994年   24篇
  1993年   36篇
  1992年   1篇
  1991年   2篇
  1990年   10篇
  1989年   10篇
  1988年   11篇
  1987年   19篇
  1986年   21篇
  1985年   9篇
  1984年   7篇
  1983年   4篇
  1982年   18篇
  1981年   6篇
  1980年   6篇
  1979年   1篇
  1977年   9篇
  1976年   7篇
  1975年   7篇
  1971年   1篇
排序方式: 共有629条查询结果,搜索用时 15 毫秒
101.

Objectives

The aim of this paper is to demonstrate, by means of a review of the literature and presentation of an illustrative case, the successful management of traumatic dental avulsion with replantation and stabilizing orthodontic therapy.

Materials and methods

The authors report a case of traumatic loss of the first right upper incisor (11). Treatment consisted of replantation of the tooth and stabilization of the implant with a fixed orthodontic appliance.

Results

After 27 years, clinical and radiological findings show no root resorption, and the incisor is viable and stable.

Conclusions

Dental replantation after traumatic avulsion is now a valid option for treatment of traumatic avulsion. It allows functional and esthetics rehabilitation of the dental element.  相似文献   
102.
Rosenstock  J  Lorber DL  Gnudi  L 《中国处方药》2010,(7):60-60
本研究在于确定胃酸抑制剂是否会增加选择性手术患者术后发生肺炎的风险。 此项人群前瞻性队列研究于1992年4月1日-2008年3月31日在加拿大开展。年龄大于65岁已确定进行选择性手术的患者入组。将本年度在手术前服用过两种或以上胃酸抑制剂的患者以及术前90天内服用过至少一种胃酸抑制剂的患者入试验组,  相似文献   
103.

Introduction  

Although inhalation of 80 parts per million (ppm) of hydrogen sulfide (H2S) reduces metabolism in mice, doses higher than 200 ppm of H2S were required to depress metabolism in rats. We therefore hypothesized that higher concentrations of H2S are required to reduce metabolism in larger mammals and humans. To avoid the potential pulmonary toxicity of H2S inhalation at high concentrations, we investigated whether administering H2S via ventilation of an extracorporeal membrane lung (ECML) would provide means to manipulate the metabolic rate in sheep.  相似文献   
104.
105.
CE Rubin 《Gastroenterology》1997,112(6):2108-2110
This article has no abstract. To view the article, select the "View Print Version (PDF)" link above.  相似文献   
106.
Renal allograft loss from chronic rejection or cyclosporine toxicity (CsAT) is characterized by progressive interstitial fibrosis, yet the protein composition of these lesions is unknown. The normal tubular basement membrane (TBM) contains laminin (LM), collagen IV (containing collagen IV alpha chain 1 [COL4A1] and COL4A2), thrombospondin (TSP), and fibronectin (FN). Only TSP and FN extend beyond the TBM into the interstitial space. Very scanty amounts of interstitial collagens (I and III) are detected in the interstitium. In a pilot study of human renal allograft biopsy specimens, three patterns of extracellular matrix (ECM) composition were identified. Pattern 1 showed no change in ECM composition; pattern 2 showed generalized accumulation of collagens I and III in the interstitium; and pattern 3 showed new expression of COL4A3 and LM-beta2 in the proximal TBM. Criteria were established for the clinicopathological diagnosis of CsAT and rejection. These diagnoses were correlated with the ECM composition in 22 renal allograft biopsy specimens. Control groups were examined in a similar manner and included native kidney biopsy specimens from patients with other allografts (n = 7), renal biopsy specimens from patients with glomerular disease (n = 9), and renal allograft biopsy specimens from patients without clinicopathological evidence of renal disease. These data show that rejection is associated with pattern 3 and CsAT is associated with pattern 2. Thus, detection of ECM composition may be a useful adjunct to standard microscopy in distinguishing rejection from CsAT in renal allograft biopsy specimens. These data suggest that interstitial fibrosis associated with rejection and CsAT result from different pathogenic mechanisms.  相似文献   
107.
108.
Purpose of ReviewWith increased understanding of the biomechanical function of the acetabular labrum, more attention has been directed towards surgical techniques that preserve or restore normal joint anatomy. While labral repair has been shown to produce superior outcomes to labral debridement, repair is not always possible in the setting of severe labral intrasubstance tearing or deficiency. These patients were previously left without suitable arthroscopic treatment options.Recent FindingsLabral reconstruction is an emerging procedure that has been shown to offer promising outcomes for traditionally difficult-to-treat hip pathology. Short- and mid-term follow-up studies have consistently demonstrated significant improvement in patient-reported outcomes, function, and patient satisfaction postoperatively, often despite less favorable preoperative characteristics.SummaryLabral reconstruction is a viable arthroscopic treatment option that has been shown to reliably produce clinically meaningful results in patients with severe labral pathology that is not amenable to repair/refixation or augmentation.  相似文献   
109.
110.
目的:探讨磁共振氢质子谱(1H-MRS)对原发性单侧起病帕金森病的诊断价值。方法:未经治疗的原发单侧症状PD患者50例为PD组,健康人42名为对照组。两组分别予以双侧壳核MRS检查,由仪器自带软件自动计算得双侧壳核代谢物比值:NAA/Cr,Cho/Cr,NAA/Cho。结果:PD组患者其症状对侧壳核NAA/cr比值分别较同侧及健康对照组双侧壳核相应比值均值明显下降(分别为1.23±0.22,1.38±0.33,1.33±0.16;t=2.616,P=0.01和t=2.324,P=0.02),而其NAA/Cho、Cho/Cr比值较同侧及对照组相应比值均值无显著差异。症状同侧壳核NAA/cr、NAA/Cho、Cho/Cr较对照组无明显差异。结论:原发性单侧症状PD其症状的对侧壳核早期就可能存在神经元的缺失或胶质增生,提示壳核磁共振波谱分析可为早期PD的临床诊断提供较为可靠的客观依据。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号